Dexmedetomidine for the Treatment of Delirium After Heart Surgery
Status:
Terminated
Trial end date:
2012-06-01
Target enrollment:
Participant gender:
Summary
Primary hypothesis: Dexmedetomidine is equal or superior to haloperidol and placebo in the
treatment of psychomotor confusion in patients who are recovering from heart surgery.
Study design:
Multi-centre, prospective, randomised, placebo-controlled double-blind study of
dexmedetomidine vs. haloperidol for treatment of psychomotor confusion after cardiac surgery.
Data will be analyzed in two steps: The primary comparison is between placebo and
dexmedetomidine. If the effect of dexmedetomidine is significant, a secondary comparison
between dexmedetomidine and haloperidol will follow.